Patients (%) with CRS events by cycle and grade in the overall R/R LBCL population (safety evaluable population).
CRS
B-CELL LYMPHOMA, CYTOKINE RELEASE SYNDROME
CRS was graded using American Society for Transplantation and Cellular Therapy criteria. C, cycle; CRS, cytokine release syndrome; D, day; LBCL, large B-cell lymphoma; NA, not applicable; R/R, relapsed/refractory.
